131 related articles for article (PubMed ID: 22966790)
1. Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development.
Aref D; Moffatt CJ; Agnihotri S; Ramaswamy V; Dubuc AM; Northcott PA; Taylor MD; Perry A; Olson JM; Eberhart CG; Croul SE
Brain Pathol; 2013 Mar; 23(2):178-91. PubMed ID: 22966790
[TBL] [Abstract][Full Text] [Related]
2. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the ciliary GTPase Arl13b suppresses Sonic hedgehog overactivation and inhibits medulloblastoma formation.
Bay SN; Long AB; Caspary T
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1570-1575. PubMed ID: 29378965
[TBL] [Abstract][Full Text] [Related]
4. The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma.
Sarić N; Selby M; Ramaswamy V; Kool M; Stockinger B; Hogstrand C; Williamson D; Marino S; Taylor MD; Clifford SC; Basson MA
Sci Rep; 2020 Jan; 10(1):148. PubMed ID: 31924815
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma.
Robinson MH; Maximov V; Lallani S; Farooq H; Taylor MD; Read RD; Kenney AM
Sci Rep; 2019 Sep; 9(1):13611. PubMed ID: 31541170
[TBL] [Abstract][Full Text] [Related]
6. Targeted treatment for sonic hedgehog-dependent medulloblastoma.
Kieran MW
Neuro Oncol; 2014 Aug; 16(8):1037-47. PubMed ID: 24951114
[TBL] [Abstract][Full Text] [Related]
7. Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.
Leskoske KL; Garcia-Mansfield K; Sharma R; Krishnan A; Rusert JM; Mesirov JP; Wechsler-Reya RJ; Pirrotte P
J Proteome Res; 2022 Sep; 21(9):2124-2136. PubMed ID: 35977718
[TBL] [Abstract][Full Text] [Related]
8. Cerebellum development and medulloblastoma.
Roussel MF; Hatten ME
Curr Top Dev Biol; 2011; 94():235-82. PubMed ID: 21295689
[TBL] [Abstract][Full Text] [Related]
9. Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.
Kawauchi D; Ogg RJ; Liu L; Shih DJH; Finkelstein D; Murphy BL; Rehg JE; Korshunov A; Calabrese C; Zindy F; Phoenix T; Kawaguchi Y; Gronych J; Gilbertson RJ; Lichter P; Gajjar A; Kool M; Northcott PA; Pfister SM; Roussel MF
Oncogene; 2017 Sep; 36(37):5231-5242. PubMed ID: 28504719
[TBL] [Abstract][Full Text] [Related]
10. Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.
Kresbach C; Holst L; Schoof M; Leven T; Göbel C; Neyazi S; Tischendorf J; Loose C; Wrzeszcz A; Yorgan T; Rutkowski S; Schüller U
Neuro Oncol; 2024 Apr; 26(4):609-622. PubMed ID: 37767814
[TBL] [Abstract][Full Text] [Related]
11. Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging.
Linke F; Johnson JEC; Kern S; Bennett CD; Lourdusamy A; Lea D; Clifford SC; Merry CLR; Stolnik S; Alexander MR; Peet AC; Scurr DJ; Griffiths RL; Grabowska AM; Kerr ID; Coyle B
Acta Neuropathol Commun; 2023 Jan; 11(1):6. PubMed ID: 36631900
[TBL] [Abstract][Full Text] [Related]
12. Developmental basis of SHH medulloblastoma heterogeneity.
Gold MP; Ong W; Masteller AM; Ghasemi DR; Galindo JA; Park NR; Huynh NC; Donde A; Pister V; Saurez RA; Vladoiu MC; Hwang GH; Eisemann T; Donovan LK; Walker AD; Benetatos J; Dufour C; Garzia L; Segal RA; Wechsler-Reya RJ; Mesirov JP; Korshunov A; Pajtler KW; Pomeroy SL; Ayrault O; Davidson SM; Cotter JA; Taylor MD; Fraenkel E
Nat Commun; 2024 Jan; 15(1):270. PubMed ID: 38191555
[TBL] [Abstract][Full Text] [Related]
13. The
Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated astrocytes promote tumor progression of Sonic Hedgehog medulloblastoma by secreting lipocalin-2.
Li H; Liu Y; Liu Y; Xu L; Sun Z; Zheng D; Liu X; Song C; Zhang Y; Liang H; Yang B; Tian X; Luo J; Chang Q
Brain Pathol; 2024 Jan; 34(1):e13212. PubMed ID: 37721122
[TBL] [Abstract][Full Text] [Related]
15. Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.
Luo Z; Xia M; Shi W; Zhao C; Wang J; Xin D; Dong X; Xiong Y; Zhang F; Berry K; Ogurek S; Liu X; Rao R; Xing R; Wu LMN; Cui S; Xu L; Lin Y; Ma W; Tian S; Xie Q; Zhang L; Xin M; Wang X; Yue F; Zheng H; Liu Y; Stevenson CB; de Blank P; Perentesis JP; Gilbertson RJ; Li H; Ma J; Zhou W; Taylor MD; Lu QR
Nature; 2022 Dec; 612(7941):787-794. PubMed ID: 36450980
[TBL] [Abstract][Full Text] [Related]
16. The genetic landscape of the childhood cancer medulloblastoma.
Parsons DW; Li M; Zhang X; Jones S; Leary RJ; Lin JC; Boca SM; Carter H; Samayoa J; Bettegowda C; Gallia GL; Jallo GI; Binder ZA; Nikolsky Y; Hartigan J; Smith DR; Gerhard DS; Fults DW; VandenBerg S; Berger MS; Marie SK; Shinjo SM; Clara C; Phillips PC; Minturn JE; Biegel JA; Judkins AR; Resnick AC; Storm PB; Curran T; He Y; Rasheed BA; Friedman HS; Keir ST; McLendon R; Northcott PA; Taylor MD; Burger PC; Riggins GJ; Karchin R; Parmigiani G; Bigner DD; Yan H; Papadopoulos N; Vogelstein B; Kinzler KW; Velculescu VE
Science; 2011 Jan; 331(6016):435-9. PubMed ID: 21163964
[TBL] [Abstract][Full Text] [Related]
17. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
Genovesi LA; Millar A; Tolson E; Singleton M; Hassall E; Kojic M; Brighi C; Girard E; Andradas C; Kuchibhotla M; Bhuva DD; Endersby R; Gottardo NG; Bernard A; Adolphe C; Olson JM; Taylor MD; Davis MJ; Wainwright BJ
Genome Med; 2021 Jun; 13(1):103. PubMed ID: 34154646
[TBL] [Abstract][Full Text] [Related]
18. Meningeal macrophages inhibit chemokine signaling in pre-tumor cells to suppress mouse medulloblastoma initiation.
Pokrajac NT; Tokarew NJA; Gurdita A; Ortin-Martinez A; Wallace VA
Dev Cell; 2023 Oct; 58(20):2015-2031.e8. PubMed ID: 37774709
[TBL] [Abstract][Full Text] [Related]
19. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules.
Bibbò F; Asadzadeh F; Boccia A; Sorice C; Bianco O; Saccà CD; Majello B; Donofrio V; Bifano D; De Martino L; Quaglietta L; Cristofano A; Covelli EM; Cinalli G; Ferrucci V; De Antonellis P; Zollo M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612726
[TBL] [Abstract][Full Text] [Related]
20. FAIM2 is correlated with metastasis of medulloblastoma through bioinformatics analysis.
Zhou X; Zhao H
Medicine (Baltimore); 2023 Apr; 102(16):e33591. PubMed ID: 37083768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
